213
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Characterization of Domain V Mutations in Clinical Isolates of Helicobacter pylori in Pakistan and Their Effect on Clarithromycin MIC

, &
Pages 3393-3403 | Published online: 24 Aug 2021

References

  • NgHK, GohKL, ChuahKH, et al. Sequencing-based detection of 23S rRNA domain V mutations in treatment-naïve Helicobacter pylori patients from Malaysia. J Glob Antimicrob Resist. 2020;23:345–348. doi:10.1016/j.jgar.2020.10.012.Epub 2020 Nov 133137535
  • AlbashaAM, ElnoshMM, OsmanEH, et al. Helicobacter pylori 23S rRNA gene A2142G, A2143G, T2182C, and C2195T mutations associated with clarithromycin resistance detected in Sudanese patients. BMC Microbiol. 2021;21:1–6.33386072
  • MarquesAT, VitorJMB, SantosA, et al. Trends in H. pylori resistance to clarithromycin: from phenotypic to genomic approaches. Microbial Genomics. 2020 Mar;6(3):e000344.doi:10.1099/mgen.0.000344
  • VazirzadehJ, FalahiJ, MoghimS, et al. Molecular assessment of resistance to clarithromycin in Helicobacter pylori strains isolated from patients with dyspepsia by fluorescent in situ hybridization in the center of Iran. Biomed Res Int. 2020 Mar 27;2020:2304173.. doi:10.1155/2020/2304173.eCollection2020.
  • KocazeybekB, SakliMK, YukselP, et al. Comparison of new and classical point mutations associated with clarithromycin resistance in H. pylori strains isolated from dyspeptic patients and their effects on phenotypic clarithromycin resistance. J Med Microbiol. 2019;68(4):566–573. doi:10.1099/jmm.0.00094430724729
  • Clinical and laboratory Standards Institute (CLSI). Methods for Antimicrobial Dilutions and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria. 3rd ed. CLSI guideline M45. Wayne, PA: Clinical and Laboratory Standards Institute; 2016.
  • MattarR, LaudannaAA. Helicobacter pylori genotyping from positive CLOtest in patients with duodenal ulcer. Rev Hosp Clin. 2000;55(5):155–160. doi:10.1590/S0041-87812000000500001
  • VersalovicJ, ShortridgeD, KiblerK, et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. J Antimicrob Chemother. 1996;40:477–480. doi:10.1128/AAC.40.2.477
  • ChisholmSA, OwenRJ, TeareEL, et al. PCR-based diagnosis of Helicobacter pylori infection and real-time determination of clarithromycin resistance directly from human gastric biopsy samples. J Clin Microbiol. 2001;39:1217–1220. doi:10.1128/JCM.39.4.1217-1220.200111283030
  • SambrookJ, FritschEF, ManiatisT. Molecular Cloning: A Laboratory Manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989.
  • AthertonJC, CaoP, PeekRM, et al. Mosaicism in vacuolating cytotoxin alleles of H. pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 1999;270:17771–17777. doi:10.1074/jbc.270.30.17771
  • PenaAJ, FoxJG, FerraroMJ, et al. Molecular resistance testing of Helicobacter pylori in gastric biopsies. Arch Pathol Lab Med. 2001;125:493–497. doi:10.5858/2001-125-0493-MRTOHP11260622
  • ChattopadhyayS, PatraR, RamamurthyT, et al. Multiplex PCR assay for rapid detection and genotyping of H. pylori directly from biopsy specimens. J Clin Microbiol. 2004;42(6):2821–2824. doi:10.1128/JCM.42.6.2821-2824.200415184482
  • TaylorDE, GeZ, PurychD, et al. Cloning and sequence analysis of two copies of a 23S rRNA gene from H. pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother. 1997;41:477–480. doi:10.1128/AAC.41.12.2621
  • VeralsovicJ, OsatoMS, SpakovskyK, et al. Point mutations in the 23S rRNA gene of Helicobacter pylori-associated with different levels of clarithromycin resistance. J Antimicrob Chemother. 1997;40:283–286. doi:10.1093/jac/40.2.2839301997
  • HooiJKY, LaiWY, NgWK, et al. Global prevalence of H. pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153:420–429. doi:10.1053/j.gastro.2017.04.02228456631
  • MalfertheinerP, MegraudF, O’MorainCA, et al. Management of Helicobacter pylori infection-the maastricht IV/ florence consensus report. Gut. 2012;61:646–664. doi:10.1136/gutjnl-2012-30208422491499
  • GehlotVS, MahantaAK, MukhopadhyayKD, et al. Low level of clarithromycin-resistant H. pylori isolates with an A2143G point mutation in the 23S rRNA gene in North India. J Glob Antimicrob Resist. 2016;6:39–43. doi:10.1016/j.jgar.2016.02.00727530837
  • YakoobJ, JafriW, AbidS, et al. Role of rapid urease test and histopathology in the diagnosis of Helicobacter pylori infection in a developing country. BMC Gastroenterol. 2005;5:38. doi:10.1186/1471-230X-5-3816309551
  • YakoobJ, AbbasZ, KhanR, et al. Prevalence of non-Helicobacter pylori species in patients presenting with dyspepsia. BMC Gastroenterol. 2012;12:3. doi:10.1186/1471-230X-12-322226326
  • RasheedF, CampbellBJ, AlfizahH, et al. Analysis of clinical isolates of H. pylori in Pakistan reveals high degrees of pathogenicity and high frequencies of antibiotic resistance. Helicobacter. 2014;19:387–399. doi:10.1111/hel.1214224827414
  • TranVH, HaTMT, LePTQ, et al. Characterization of point mutations in domain V of 23S rRNA gene of clinical strains of H. pylori and clarithromycin-resistant phenotype in central Vietnam. J Glob Antimicrob Resist. 2018;16:87–91. doi:10.1016/j.jgar.2018.09.01230266639
  • NyiKN, SoeAM, HtutZM. Molecular detection of genotypic clarithromycin-resistant strains and its effect on the eradication rate of concomitant therapy in H. pylori infection. GastroHep. 2021;00: 1-7. doi:10.1002/ygh2.476
  • KhasheiR, DaraM, BazarganiA, et al. The high rate of A2142G point mutation associated with clarithromycin resistance among Iranian H. pylori clinical isolates. APMIS. 2016;124(9):787–793. doi:10.1111/apm.1256727357065
  • Zhen-HuaZ, De-qiangH, YongX, et al. Characterization of 23S rRNA gene mutation in primary and secondary clarithromycin-resistant H. pylori strains from East China. Turk J Gastroenterol. 2013;24:5–9. doi:10.4318/tjg.2013.052523794337
  • Van-doornLJ, GlupczynskiY, KustersJG, et al. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicentre validation study. Antimicrob Agents Chemother. 2001;45:1500–1504. doi:10.1128/AAC.45.5.1500-1504.200111302817
  • AlacornT, DomingoD, PrietoN, et al. PCR using 3ʹ-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. J Clin Microbiol. 2000;38:923–925. doi:10.1128/JCM.38.2.923-925.200010655418
  • RimbaraE, NoguchiN, KijimaH, et al. Mutations in the 23S rRNA gene of clarithromycin-resistant Helicobacter pylori from Japan. Int J Antimicrob Agents. 2007;30:250–254. doi:10.1016/j.ijantimicag.2007.04.00917590317
  • AlfaresiMS, ElkoushAA. Characterization of clarithromycin resistance in isolates of Helicobacter pylori from the U. A. E. Indian J Gastroenterol. 2010;29:116–120. doi:10.1007/s12664-010-0034-z20658326
  • LeeHK, ChaeHS, KangJO, et al. Multicentre study for the frequency of 23S rRNA point mutations associated with clarithromycin resistance in H. pylori in Korea. Korean J Clin Microbiol. 2008;11:12–15. doi:10.5145/KJCM.2008.11.2.84
  • LeeHJ, KimJI, CheungDY, et al. Eradication of H. pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance. J Infect Dis. 2013;208:1123–1130. doi:10.1093/infdis/jit28723801607
  • YakoobJ, JaffariW, AbbasZ, et al. Risk factors associated with H. pylori infection treatment failure in a high prevalence area. Epidemiol Infect. 2011;139:581–590. doi:10.1017/S095026881000122620525411
  • AhmadN, ZakariaWR, AbdullahSA, et al. Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori.. World J Gastroenterol. 2009;15:3161–3165. doi:10.3748/wjg.15.316119575497
  • WolleK, LeodolterA, MalfertheinerP, et al. Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol. 2002;51:705–709. doi:10.1099/0022-1317-51-8-70512171304
  • FelloneCA. Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada. Can J Gastroenterol. 2000;14:879–882. doi:10.1155/2000/56215911111111
  • LingTKW, LeungWK, LeeCC, et al. The antimicrobial susceptibility of Helicobacter pylori in Hong Kong (1997–2001). Helicobacter. 2002;7:327–329. doi:10.1046/j.1523-5378.2002.00101_1.x12390214
  • KimJJ, ReddyR, LeeM, et al. Analysis of metronidazole, clarithromycin, and tetracycline resistance of H. pylori isolates from Korea. J Antimicrob Chemother. 2001;47:459–461. doi:10.1093/jac/47.4.45911266421
  • LerangF, MoumB, HaugJB, et al. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?Am J Gastroenterol. 1997;92:248–253.9040200
  • LaineL, FennertyMB, OsatoM, et al. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. Am J Gastroenterol. 2000;95:3393–3398. doi:10.1111/j.1572-0241.2000.03349.x11151867
  • MohammediM, DoroudD, MassarratS, et al. Clarithromycin resistance in Iranian Helicobacter pylori strains before the introduction of clarithromycin. Helicobacter. 2003;8:79–80.12603620
  • KocazeybekB, TokmanHB. Prevalence of primary antimicrobial resistance of H. pylori in Turkey: a systematic review. Helicobacter. 2015. doi:10.1111/hel.12272
  • GhotaslouR, LeylabadloHE, AslYM. Prevalence of antibiotic resistance in H. pylori: a recent literature review. World J Methodol. 2015;5:164–174. doi:10.5662/wjm.v5.i3.16426413490
  • KleinEY, VanBoeckelTP, MartinezEM, et al. Global increase, and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci. 2018;115(15):E3463–E3470. doi:10.1073/pnas.171729511529581252
  • GarridoL, ToledoH. Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene. Helicobacter. 2007;12(5):505–509. doi:10.1111/j.1523-5378.2007.00506.x17760718
  • SeoSI, DoBJ, KangJG, et al. Helicobacter pylori eradication according to sequencing-based 23S rRNA point mutation associated with clarithromycin resistance. J Clin Med. 2020;9:54. doi:10.3390/jcm9010054
  • KhanR, NaharS, SultanaJ, et al. T2182C mutation in 23S rRNA is associated with clarithromycin resistance in H. pylori isolates obtained in Bangladesh. Antimicrob Agents Chemother. 2004;48(9):3567–3569. doi:10.1128/AAC.48.9.3567-3569.200415328128
  • KimKS, KangJO, EunCS, et al. Mutations in the 23S rRNA gene of Helicobacter pylori-associated with clarithromycin resistance. J Korean Med Sci. 2002;17:599–603. doi:10.3346/jkms.2002.17.5.59912378008
  • GomezJE, Kaufmann-MalagaBB, WivaggCN, et al. Ribosomal mutations promote the evolution of antibiotic resistance in a multidrug environment. eLife. 2017;6:e20420. doi:10.7554/eLife.2042028220755